Glucagon-like peptide-1 receptor agonists as a novel therapy in Type II Diabetes Mellitus
Aparna Sarode Introduction: Type II diabetes mellitus (T2DM) is a chronic metabolic disease in which pancreatic β-cells do not produce sufficient insulin and peripheral cells become insulin resistant.1 Insulin resistant cells have a reduced intake of glucose which leads to the hyperglycemic condition characteristic of T2DM. Glucagon-like peptide-1 receptor (GLP-1R)…